MIZOLLEN

This brand name is authorized in Germany, France, Israel, Netherlands, Tunisia, United Kingdom

Active ingredients

The drug MIZOLLEN contains one active pharmaceutical ingredient (API):

1 Mizolastine UNII 244O1F90NA - MIZOLASTINE

Mizolastine possesses antihistamine and antiallergic properties due to a specific and selective antagonism of peripheral histamine H1 receptors. Read about Mizolastine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MIZOLLEN Modified-release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX25	Mizolastine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00121672, 00121778, 00839056, 00839062, 01393651, 01393705, 01393711, 01413359, 01413365, 01413371, 01588544, 01588627, 01687306, 03211855, 03211861, 03211878, 08545182, 08545199
Country: FR	Base de données publique des médicaments	Identifier(s): 64991179
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 22294
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4116
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 48291
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9043871